Forskning
Udskriv Udskriv
Switch language
Bispebjerg Hospital - en del af Københavns Universitetshospital
Udgivet

Shift From Adalimumab Originator to Biosimilars in Denmark

Publikation: Bidrag til tidsskriftLetterpeer review

Harvard

APA

CBE

MLA

Vancouver

Author

Bibtex

@article{e09aca06bd00484c8732374faefec199,
title = "Shift From Adalimumab Originator to Biosimilars in Denmark",
author = "Jensen, {Thomas Bo} and Kim, {Seoyoung C} and Espen Jimenez-Solem and Dorthe Bartels and Christensen, {Hanne Rolighed} and Andersen, {Jon Tr{\ae}rup}",
year = "2020",
month = jun,
day = "1",
doi = "10.1001/jamainternmed.2020.0338",
language = "English",
volume = "180",
pages = "902--903",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "6",

}

RIS

TY - JOUR

T1 - Shift From Adalimumab Originator to Biosimilars in Denmark

AU - Jensen, Thomas Bo

AU - Kim, Seoyoung C

AU - Jimenez-Solem, Espen

AU - Bartels, Dorthe

AU - Christensen, Hanne Rolighed

AU - Andersen, Jon Trærup

PY - 2020/6/1

Y1 - 2020/6/1

UR - http://www.scopus.com/inward/record.url?scp=85082406163&partnerID=8YFLogxK

U2 - 10.1001/jamainternmed.2020.0338

DO - 10.1001/jamainternmed.2020.0338

M3 - Letter

C2 - 32227137

VL - 180

SP - 902

EP - 903

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 6

ER -

ID: 59855815